Insider Trading Alert - IMPV, MDSO And IPGP Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, April 7, 2014, 65 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $531.18 to $3,032,034.00.

Highlighted Stocks Traded by Insiders:

Imperva (IMPV) - FREE Research Report

Kramer Shlomo who is President and CEO at Imperva sold 60,000 shares at $50.53 on April 7, 2014. Following this transaction, the President and CEO owned 2.4 million shares meaning that the stake was reduced by 2.41% with the 60,000-share transaction.

The shares most recently traded at $49.20, down $1.33, or 2.71% since the insider transaction. Historical insider transactions for Imperva go as follows:

  • 4-Week # shares sold: 243
  • 12-Week # shares sold: 243
  • 24-Week # shares sold: 10,667

The average volume for Imperva has been 287,900 shares per day over the past 30 days. Imperva has a market cap of $1.3 billion and is part of the technology sector and computer software & services industry. Shares are up 2.04% year-to-date as of the close of trading on Monday.

Imperva, Inc. develops, markets, sells, services, and supports data center security solutions that protect high value applications and data assets in physical and virtual data centers. The company operates in two segments, Imperva and Incapsula. Currently there are 7 analysts that rate Imperva a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IMPV - FREE

TheStreet Quant Ratings rates Imperva as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity and feeble growth in its earnings per share. Get the full Imperva Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Medidata Solutions (MDSO) - FREE Research Report

Sherif Tarek who is Chairman & CEO at Medidata Solutions sold 20,000 shares at $55.05 on April 7, 2014. Following this transaction, the Chairman & CEO owned 920,626 shares meaning that the stake was reduced by 2.13% with the 20,000-share transaction.

The shares most recently traded at $47.34, down $7.71, or 16.29% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares sold: 20,000
  • 12-Week # shares sold: 145,347
  • 24-Week # shares sold: 345,679

The average volume for Medidata Solutions has been 669,000 shares per day over the past 30 days. Medidata Solutions has a market cap of $2.6 billion and is part of the technology sector and computer software & services industry. Shares are down 20.78% year-to-date as of the close of trading on Monday.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences in the United States and internationally. The company has a P/E ratio of 211.2. Currently there are 6 analysts that rate Medidata Solutions a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings rates Medidata Solutions as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and generally higher debt management risk. Get the full Medidata Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

IPG Photonics Corporation (IPGP) - FREE Research Report

Gapontsev Valentin P who is CEO & Chairman of the Board at IPG Photonics Corporation sold 4,500 shares at $75.03 on April 7, 2014. Following this transaction, the CEO & Chairman of the Board owned 551,431 shares meaning that the stake was reduced by 0.81% with the 4,500-share transaction.

Ip Fibre Devices Ltd who is 10% Owner at IPG Photonics Corporation sold 3,467 shares at $75.04 on April 7, 2014. Following this transaction, the 10% Owner owned 7.3 million shares meaning that the stake was reduced by 0.05% with the 3,467-share transaction.

Valentin Gapontsev Trust I who is 10% Owner at IPG Photonics Corporation sold 3,667 shares at $75.03 on April 7, 2014. Following this transaction, the 10% Owner owned 7.8 million shares meaning that the stake was reduced by 0.05% with the 3,667-share transaction.

The shares most recently traded at $74.72, down $0.31, or 0.41% since the insider transaction. Historical insider transactions for IPG Photonics Corporation go as follows:

  • 4-Week # shares sold: 120,667
  • 12-Week # shares sold: 221,334
  • 24-Week # shares sold: 241,584

The average volume for IPG Photonics Corporation has been 412,100 shares per day over the past 30 days. IPG Photonics Corporation has a market cap of $3.9 billion and is part of the technology sector and electronics industry. Shares are down 4.07% year-to-date as of the close of trading on Monday.

IPG Photonics Corporation develops and manufactures fiber lasers, fiber amplifiers, and diode lasers that are used in various applications, primarily in materials processing. The company has a P/E ratio of 23.1. Currently there are 7 analysts that rate IPG Photonics Corporation a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on IPGP - FREE

TheStreet Quant Ratings rates IPG Photonics Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full IPG Photonics Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Replay: Jim Cramer on Tariffs, the Market Rally, Caterpillar and Micron

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: When Planning for Retirement, Don't Underestimate Your Life Span

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Video: Here's What May Come Next for Theranos Founder and CEO Elizabeth Holmes

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

Charlie Gasparino Says GE Is Reportedly Looking to Slash Its Dividend Again

GE Confirms $11.1 Billion Transportation Merger With Wabtec

GE Confirms $11.1 Billion Transportation Merger With Wabtec